Ekso Bionics Holdings, Inc.
EKSO
$12.40
$0.403.33%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -36.95% | 31.42% | -12.13% | 15.69% | -6.19% |
| Total Depreciation and Amortization | 13.32% | -9.83% | -5.04% | -6.90% | -7.87% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -13.85% | 295.14% | -359.86% | -139.69% | 466.90% |
| Change in Net Operating Assets | -5,239.29% | -175.21% | 99.54% | 178.78% | -103.06% |
| Cash from Operations | -202.23% | 9.49% | -28.99% | 43.31% | 9.53% |
| Capital Expenditure | -500.00% | -50.00% | -- | -25.00% | 51.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -500.00% | -50.00% | -- | -25.00% | 51.16% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -638.98% | 0.00% | 0.00% | 0.32% |
| Issuance of Common Stock | -- | -- | 1,874.47% | -3.22% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,030.25% | -109.32% | 332.45% | -3.50% | -190.23% |
| Foreign Exchange rate Adjustments | 45.16% | -1,100.00% | 166.67% | 131.82% | -55.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13.67% | -204.69% | 3.50% | 869.57% | -38.49% |